245 related articles for article (PubMed ID: 24488406)
1. On-the-road driving performance and driving-related skills in older untreated insomnia patients and chronic users of hypnotics.
Leufkens TR; Ramaekers JG; de Weerd AW; Riedel WJ; Vermeeren A
Psychopharmacology (Berl); 2014 Jul; 231(14):2851-65. PubMed ID: 24488406
[TBL] [Abstract][Full Text] [Related]
2. Residual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls: a placebo controlled crossover study.
Leufkens TR; Ramaekers JG; de Weerd AW; Riedel WJ; Vermeeren A
Psychopharmacology (Berl); 2014 Jul; 231(14):2785-98. PubMed ID: 24458443
[TBL] [Abstract][Full Text] [Related]
3. Sleep and sleep disorders in chronic users of zopiclone and drug-free insomniacs.
Sivertsen B; Omvik S; Pallesen S; Nordhus IH; Bjorvatn B
J Clin Sleep Med; 2009 Aug; 5(4):349-54. PubMed ID: 19968013
[TBL] [Abstract][Full Text] [Related]
4. Middle-of-the-night hypnotic use in a large national health plan.
Roth T; Berglund P; Shahly V; Shillington AC; Stephenson JJ; Kessler RC
J Clin Sleep Med; 2013 Jul; 9(7):661-8. PubMed ID: 23853559
[TBL] [Abstract][Full Text] [Related]
5. On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly.
Vermeeren A; Vets E; Vuurman EF; Van Oers AC; Jongen S; Laethem T; Heirman I; Bautmans A; Palcza J; Li X; Troyer MD; Wrishko R; McCrea J; Sun H
Psychopharmacology (Berl); 2016 Sep; 233(18):3341-51. PubMed ID: 27424295
[TBL] [Abstract][Full Text] [Related]
6. Hypnotics and actual driving performance.
O'Hanlon JF; Volkerts ER
Acta Psychiatr Scand Suppl; 1986; 332():95-104. PubMed ID: 3554901
[TBL] [Abstract][Full Text] [Related]
7. Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring.
Staner L; Ertlé S; Boeijinga P; Rinaudo G; Arnal MA; Muzet A; Luthringer R
Psychopharmacology (Berl); 2005 Oct; 181(4):790-8. PubMed ID: 16025317
[TBL] [Abstract][Full Text] [Related]
8. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone.
Boyle J; Trick L; Johnsen S; Roach J; Rubens R
Hum Psychopharmacol; 2008 Jul; 23(5):385-97. PubMed ID: 18350566
[TBL] [Abstract][Full Text] [Related]
9. Driving performance and neurocognitive skills of long-term users of benzodiazepine anxiolytics and hypnotics.
van der Sluiszen NNJJM; Vermeeren A; Verster JC; van de Loo AJAE; van Dijken JH; Veldstra JL; Brookhuis KA; de Waard D; Ramaekers JG
Hum Psychopharmacol; 2019 Nov; 34(6):e2715. PubMed ID: 31837049
[TBL] [Abstract][Full Text] [Related]
10. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
[TBL] [Abstract][Full Text] [Related]
11. Cognitive, psychomotor and polysomnographic effects of trazodone in primary insomniacs.
Roth AJ; McCall WV; Liguori A
J Sleep Res; 2011 Dec; 20(4):552-8. PubMed ID: 21623982
[TBL] [Abstract][Full Text] [Related]
12. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
[TBL] [Abstract][Full Text] [Related]
13. An assessment of short-acting hypnotics.
Mendelson WB; Jain B
Drug Saf; 1995 Oct; 13(4):257-70. PubMed ID: 8573298
[TBL] [Abstract][Full Text] [Related]
14. Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia.
Partinen M; Hirvonen K; Hublin C; Halavaara M; Hiltunen H
Sleep Med; 2003 Nov; 4(6):553-61. PubMed ID: 14607350
[TBL] [Abstract][Full Text] [Related]
15. The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers.
Miyata A; Iwamoto K; Kawano N; Kohmura K; Yamamoto M; Aleksic B; Ebe K; Noda A; Noda Y; Iritani S; Ozaki N
Psychopharmacology (Berl); 2015 Jun; 232(12):2127-37. PubMed ID: 25533998
[TBL] [Abstract][Full Text] [Related]
16. Effects of the use of hypnotics on cognition.
Vermeeren A; Coenen AM
Prog Brain Res; 2011; 190():89-103. PubMed ID: 21531246
[TBL] [Abstract][Full Text] [Related]
17. Psychological treatment for insomnia in the regulation of long-term hypnotic drug use.
Morgan K; Dixon S; Mathers N; Thompson J; Tomeny M
Health Technol Assess; 2004 Feb; 8(8):iii-iv, 1-68. PubMed ID: 14960254
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.
Mayer G; Wang-Weigand S; Roth-Schechter B; Lehmann R; Staner C; Partinen M
Sleep; 2009 Mar; 32(3):351-60. PubMed ID: 19294955
[TBL] [Abstract][Full Text] [Related]
19. Electroencephalography during on-the-road driving in older untreated insomnia patients and normal sleepers.
Perrier J; Leufkens TR; Bulla J; Jongen S; Bocca ML; Ramaekers JG; Vermeeren A
Biol Psychol; 2015 Jul; 109():20-8. PubMed ID: 25882903
[TBL] [Abstract][Full Text] [Related]
20. Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo.
Leufkens TR; Vermeeren A
J Clin Psychopharmacol; 2009 Oct; 29(5):432-8. PubMed ID: 19745642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
